A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) a powerful predictor of long term mortality in patients treated with cardiac resynchronization therapy
2013
European Heart Journal
Resynchronisation therapy width in Group I, p = 0.042. Final values of the QRSst and QRSno-st width were lower in Group I, p = 0.015 and p = 0.001 respectively. There are no significant differences in baseline QRS and QRSst between the groups. End-systolic and end-diastolic LV volume significantly decreased in both groups; reduction in the end-systolic volume was greater in Group I compared to Group II, p = 0.039. EF increased in both groups; percentage increase in EF was significantly higher
doi:10.1093/eurheartj/eht309.p3186
fatcat:bj2wgarkqjfdfopminp6efv6ma